Piper Sandler analyst Edward Tenthoff maintained a Hold rating on Seres Therapeutics (MCRB – Research Report) today and set a price target of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback